STRO
Sutro Biopharma
14.70$
+1.5%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -74.7% | +0.0% | +15.9% | -76.9% | +43.4% | -1.5% | +37.4% | +143.6% | -54.8% | +22.0% | +16.6% | -7.9% | -36.7% | +32.4% | +88.2% | -53.6% | +77.1% | +91.3% | -69.6% | +25.1% | -44.6% | +376.4% | -10.5% | -65.7% | +46.8% | -17.8% | +62.5% | +572.0% | -88.6% | +97.6% | -66.9% | +73.8% | +17.5% | +266.4% | -84.8% | +20.2% | +24.7% | -32.3% | – | |
| – | -75.5% | +0.0% | +5.8% | -9.3% | +5.5% | +5.1% | -8.1% | +17.0% | +2.7% | +6.3% | +4.7% | +2.9% | +1.3% | -2.1% | +12.3% | +17.4% | -0.8% | +12.2% | +5.1% | +12.5% | +0.2% | -93.2% | +1.4% | +1,972.8% | -94.8% | +1,743.6% | -99.0% | +298.8% | +1.7% | +1.6% | +0.5% | -196.6% | – | – | +0.0% | -14.5% | -21.3% | – | – | |
| – | -86.5% | +0.0% | +75.2% | -318.2% | – | – | – | – | -252.4% | – | – | – | – | – | – | – | – | – | -760.0% | – | – | – | -10.5% | -237.2% | – | -346.0% | – | +572.0% | -90.1% | +112.6% | -64.4% | +73.8% | +17.5% | +266.4% | -84.8% | +20.2% | +13.7% | -25.7% | – | |
| – | -70.3% | +0.0% | +5.8% | +10.8% | -13.6% | +5.1% | -8.1% | +17.0% | +2.7% | +6.3% | +4.7% | +2.9% | +1.3% | -2.1% | +12.3% | +17.4% | -0.8% | +12.2% | +5.1% | +12.5% | +0.2% | +7.8% | -1.9% | +36.0% | -8.7% | +5.6% | +9.8% | +17.7% | +5.8% | +9.0% | +0.1% | +14.4% | -27.4% | -25.7% | +4.0% | -8.1% | -0.2% | -13.3% | – | |
| – | -75.0% | +0.0% | +32.1% | -16.9% | +8.5% | -8.5% | +32.4% | +41.5% | +1.9% | +4.6% | +0.6% | +7.1% | +0.2% | -0.8% | +5.0% | +14.4% | +7.0% | +12.9% | +32.2% | -5.0% | -4.6% | +0.7% | -3.3% | +0.5% | +5.4% | -3.3% | +1.8% | +10.1% | -24.3% | -2.8% | +15.8% | -37.0% | +47.0% | -22.1% | -15.5% | -0.9% | -12.4% | +3.3% | – | |
| – | -93.6% | +0.0% | +399.8% | +3.5% | -8.9% | +1.7% | +1.1% | +24.3% | +2.4% | +5.7% | +3.3% | -65.2% | +0.2% | -0.8% | +5.0% | +14.4% | +7.0% | +12.9% | +32.2% | -5.0% | -4.6% | +215.7% | -2.4% | -68.2% | +273.1% | -72.7% | +306.3% | +15.8% | -3.9% | +7.0% | +5.3% | +4.7% | +7.3% | -21.9% | -13.3% | -22.1% | -5.4% | -7.3% | – | |
| – | -211.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -231.1% | – | – | – | – | – | – | – | – | – | – | |
| – | -35.9% | +100.0% | -70.0% | +60.4% | +1.6% | +32.4% | -4.7% | -12.2% | +173.6% | +6.2% | -7.4% | -28.4% | +29.3% | +179.8% | -21.6% | -2.8% | -61.9% | -1.3% | -3.2% | -25.4% | +7.4% | -9.6% | +369.4% | -75.1% | +330.9% | +12.4% | +158.4% | +0.7% | +7.6% | -3.8% | -12.5% | +9.9% | +22.5% | -9.4% | +7.9% | -0.7% | -8.3% | +4.2% | – | |
| – | -186.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | -42.6% | -447.4% | – | – | – | – | – | – | – | – | – | – | – | – | -224.2% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | +803.6% | -92.0% | -100.0% | – | -100.0% | – | -4.4% | -14.2% | -16.0% | -20.9% | +361.0% | -21.6% | -197.2% | – | -1.3% | -3.2% | -25.4% | -103.6% | – | -168.9% | – | -84.2% | -61.8% | +1,117.9% | +759.5% | -89.1% | -99.5% | – | – | – | – | – | – | – | – | – | |
| – | -186.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | -42.6% | -447.4% | – | – | – | – | – | – | – | – | – | – | – | – | -287.4% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -106,046.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -185.9% | – | – | – | – | – | -4,248.0% | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.